Xencor Inc (XNCR) is the lead sponsor of 5 active clinical trials listed on ClinicalTrials.gov[3], including 2 Phase 2[1], 4 Phase 1[2].
No Form 4 insider filings for XNCR were recorded at the SEC in the past 30 days[4].
XNCR is tracked by BiotechSigns with a current catalyst score of 38/100 and grade D. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.
Xencor Inc (XNCR) is the lead sponsor of 5 active clinical trials listed on ClinicalTrials.gov[3], including 2 Phase 2[1], 4 Phase 1[2].
No Form 4 insider filings for XNCR were recorded at the SEC in the past 30 days[4].